Monthly Archives: May 2012

2012 BIO International Convention Keynotes: Back to Basics

Jim Greenwood

The 2012 BIO International Convention is a few short weeks away, and we are looking forward to this opportunity to come together for connections and partnerships that will lead to tomorrow’s breakthroughs. The Keynote Luncheon panels are always a highlight of the Convention. This year in Boston we decided to focus on core issues facing the global biotech community with keynote speakers and panelists who will provide timely insights on the economic, policy and business Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , ,

IP Creates Jobs for America

Map

By Mark Elliot, Executive Vice President, U.S. Chamber of Commerce’s Global Intellectual Property Center In May, the Global Intellectual Property Center (GIPC) was proud to unveil the results of our state intellectual property (IP) jobs research, which has been a year in the making. The study, IP Creates Jobs for America, provides real, tangible evidence that the economic benefits of IP are broad and far-reaching. In looking at a variety of government data on intellectual Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post

ALS Awareness Month: 10 Things You Should Know About ALS

Steve Perrin

By Steve Perrin, Ph.D., Chief Executive Officer and CSO, ALS Therapy Development Institute May is a month full of many exciting and celebratory days: college graduations, Mother’s day and Memorial Day.  It is a month typified by excitement, renewal, anticipation and remembrance.  It is also the month in the United States where we recognize all those living with ALS, commonly known as Lou Gehrig’s disease.  If you don’t know someone already living with this currently Read More >

Health  |  24 Comments  |  Email This Post
Tags: , , , ,

Only a Few Public Biotechs are Profitable, but There are More of Them Today

Of the 294 biotechs trading on public exchanges today, 248 (84%) focus on drug development. Of these 248 in the biopharmaceutical space, 81, or 33% have a drug approved. Only 32 (13%) had both a product on the market and positive net income in 2011. However, this 13% represents a significant jump from the 7.5% with positive net income we calculated for 2009. Note that this comes over a time frame in which a few profitable companies were Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , ,

The Scheduling Process

partnering-logo-btn

Scheduling for companies will kick into full gear the week of May 28th for the BIO Business Forum and participating exhibiting companies. As mentioned in a previous post, we wanted to discuss scheduling in a bit more detail, so that you understand what scheduling means, and how it impacts the way you use the Partnering System. First and foremost, meetings are only scheduled for those in Accepted/Agreed-To status. Your action item? Go in to your Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , , , ,